Skip to content

Measurement of Brown Adipose Tissue Amount of Diabetic Patients by using Near-infrared Time Resolved Spectroscopy

Measurement of Brown Adipose Tissue Amount of Diabetic Patients by using Near-infrared Time Resolved Spectroscopy - Measurement of Brown Adipose Tissue Amount of Diabetic Patients by using Near-infrared Time Resolved Spectroscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000026326
Enrollment
50
Registered
2017-02-28
Start date
2017-02-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes, Obesity

Interventions

The investigator will measure intercapillary and intravenula hemoglobin concentration at supraclavicular, deltoid and abdominal area by using near-infrared time-resolved spectroscopy (NIR-TRS).

Sponsors

The University of Tokyo Hospital
Lead Sponsor
Tokyo Medical University, Department of Sports Medicine for Health Promotion
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Diabetic patients who are more than 20 years old, given through explanation and understand the purpose of the study and who agree to participate in the study with a written informed consent.

Exclusion criteria

Exclusion criteria: - Those who disagree to participate in the study - Those who have serious diseases other than type 2 diabetes.

Design outcomes

Primary

MeasureTime frame
The Primary endpoint of the study is to measure brown adipose tissue mass of type 2 diabetes patients by using near-infrared time-resolved spectroscopy (NIR(TRS)) and to examine its relationship to adiposity including body mass index and percent body fat.

Secondary

MeasureTime frame
The secondary outcome of the study is to examine brown adipose tissue mass of type 2 diabetes patients by using NIR(TRS) and examine its relationship between age and environmental factors such as temperature as well as clinical factors such as diabetic controls and polymorphisms of genes, which were shown to be related to brown adipose mass measured by FDG-PET.

Countries

Japan

Contacts

Public ContactHironori Waki

The University of Tokyo Hospital Department of Diabetes and Metabolic Diseases

wakih-int@h.u-tokyo.ac.jp+81-3-3815-5411-30254

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026